SCHEMBL15570476

SCHEMBL15570476

Cc1ncc([N+](=O)[O-])n1C(CCO)CS(N)(=O)=O

nearest known ligand 0.50

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CA1 P00915 8/20 0.50
CA2 P00918 8/20 0.50
CA9 Q16790 8/20 0.50
MAPK1 P28482 2/20 0.48
LMNA P02545 2/20 0.48
ALDH1A1 P00352 2/20 0.48
THRB P10828 2/20 0.48
TSHR P16473 1/20 0.48
CA12 O43570 7/20 0.44
ATM Q13315 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.41
CHRM1 P11229 1/20 0.41
GLA P06280 1/20 0.39
EGFR P00533 3/20 0.38
ERBB2 P04626 3/20 0.38
KDM4E B2RXH2 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15570281 0.86 CA1 (0.48) CA1CA2CA9MAPK1LMNA
SCHEMBL15570075 0.84 CA1 (0.46) CA1CA2CA9MAPK1LMNA
SCHEMBL15570409 0.84 CA1 (0.46) CA1CA2CA9MAPK1LMNA
SCHEMBL11492372 0.79 ALDH1A1 (0.51) CA1CA2CA9MAPK1LMNA
SCHEMBL28736267 0.74 CHRM1 (0.56) CA1CA2CA9MAPK1LMNA
SCHEMBL8887768 0.74 MAPK1 (0.46) CA1CA2CA9MAPK1LMNA
SCHEMBL8885703 0.72 MAPK1 (0.44) CA1CA2CA9MAPK1LMNA
SCHEMBL28484741 0.72 MAPK1 (0.56) CA1CA2CA9MAPK1LMNA
SCHEMBL8595549 0.70 MAPK1 (0.42) CA1CA2CA9MAPK1LMNA
SCHEMBL15570602 0.70 CA1 (0.42) CA1CA2CA9LMNATHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014030142-A2 NITROIMIDAZOLE COMPOUNDS AND THEIR USE IN CANCER THERAPY AUCKLAND UNISERVICES LIMITED (NZ) 2014-02-27 WO claimed
WO-2014030142-A2 NITROIMIDAZOLE COMPOUNDS AND THEIR USE IN CANCER THERAPY AUCKLAND UNISERVICES LIMITED (NZ) 2014-02-27 WO disclosed